Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Brain Neoplasms 5Melanoma 3Stomach Neoplasms 2Neoplasms 2Glioma 2Glioblastoma 2Breast Neoplasms 2Thyroid Diseases 1Skin Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Paget Disease, Extramammary 1Ovarian Neoplasms 1Neuroma, Acoustic 1Lung Neoplasms 1Laryngeal Neoplasms 1Irritable Bowel Syndrome 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Gastroesophageal Reflux 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Barrett Esophagus 1Astrocytoma 1Adenomatous Polyps 1Adenolymphoma 1

Interventions

Sorafenib 3selpercatinib 2cabozantinib 2Thyroid (USP) 2Sodium 2Radiofrequency Ablation 2Metformin 2vandetanib 1tomivosertib 1temsirolimus 1repotrectinib 1pralsetinib 1pembrolizumab 1lenvatinib 1binimetinib 1apatinib 1acetaminophen, codeine drug combination 1Vitamin B 12 1Tramadol 1Thyroxine 1Thyrotropin-Releasing Hormone 1Technetium Tc 99m Sestamibi 1Surgical Procedures, Operative 1Pemetrexed 1Panobinostat 1Negative-Pressure Wound Therapy 1NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1Lysine Acetyltransferase 5 1Iodine-131 1Folic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thyroid Diseases × Fluorescein × Clear all
NCT06054178 2026-05-20

Identification of Nerves Using Fluorescein Sodium

Stanford University

Phase 2 Completed
8 enrolled 9 charts
Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡